Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist.

[1]  D. Handley,et al.  Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. , 1986, Immunopharmacology.

[2]  D. Handley,et al.  Platelet activating factor and inflammation in atherogenesis: Targets for drug development , 1986 .

[3]  D. Handley,et al.  Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. , 1985, Thrombosis and haemostasis.

[4]  P. Braquet,et al.  Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. , 1985, Immunopharmacology.

[5]  C. Galanos,et al.  Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. , 1985, Pathology, research and practice.

[6]  S. Sumida,et al.  Is platelet activating factor (PAF) a mediator of endotoxin shock? , 1985, European journal of pharmacology.

[7]  J. Gomez-Cambronero,et al.  Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. , 1985, Immunopharmacology.

[8]  D. Handley,et al.  Effect of platelet activating factor on endothelial permeability to plasma macromolecules. , 1984, Immunopharmacology.

[9]  D. Handley,et al.  Evaluation of Dose and Route Effects of Platelet Activating Factor-Induced Extravasation in the Guinea Pig , 1984, Thrombosis and Haemostasis.

[10]  T. Ono,et al.  Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. , 1984, European journal of pharmacology.

[11]  Y. Kasuya,et al.  Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF). , 1984, Journal of pharmacobio-dynamics.

[12]  F. Snyder,et al.  Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. , 1984, Circulatory shock.

[13]  S. Ghosh,et al.  Change in membrane lipid fluidity induced by phospholipase A activation: a mechanism of endotoxic shock. , 1983, Life sciences.

[14]  G. Camussi,et al.  The release of platelet-activating factor from human endothelial cells in culture. , 1983, Journal of immunology.

[15]  R. N. Pinckard.  Platelet-activating factor. , 1983, Hospital practice.

[16]  S. Tanaka,et al.  Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs. , 1983, Journal of pharmacobio-dynamics.

[17]  W. Hsueh,et al.  Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. , 1983, The American journal of pathology.

[18]  M. Sánchez-Crespo,et al.  Platelet-activating factor: an effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouse. , 1983, Immunopharmacology.

[19]  J. Benveniste,et al.  Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. , 1983, European journal of pharmacology.

[20]  J. Egido,et al.  Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. , 1982, Immunopharmacology.

[21]  G. Camussi,et al.  Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. , 1982, Journal of immunology.

[22]  L. W. Byers,et al.  Alkyl Ether Analogs of Phosphatidylcholine Are Orally Active in Hypertensive Rabbits , 1981, Hypertension.

[23]  F. Snyder,et al.  Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. , 1981, Biochimica et biophysica acta.

[24]  G. Camussi,et al.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. , 1981, Immunology.

[25]  P. Ward,et al.  Complement mediated inflammatory reactions. , 1981, Pathobiology annual.

[26]  C. Redeuilh,et al.  Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline , 1980, FEBS letters.

[27]  D. Hanahan,et al.  Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. , 1980, Biochimica et biophysica acta.

[28]  F. Snyder,et al.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. , 1979, Biochemical and biophysical research communications.

[29]  D. Hanahan,et al.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.

[30]  J. Cazenave,et al.  Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[31]  B. Vargaftig,et al.  The role of platelet-activating factor in platelet aggregation , 1979, Nature.

[32]  J. Mencia-Huerta,et al.  Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes , 1979, European journal of immunology.

[33]  T. Spector.  Refinement of the Coomassie blue method of protein quantitation: A simple and linear spectrophotometric assay for ≤0.5 to 50 μg of protein , 1978 .

[34]  P. Henson,et al.  Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. , 1977, Journal of Immunology.

[35]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.